Significant advancements in treating unresectable hepatocellular carcinoma (HCC) have emerged, particularly with immune checkpoint inhibitor (ICI) combinations that increase median survival to over two years, with some patients exceeding five years. Despite this, recent studies found no improvement in recurrence-free survival with adjuvant ICI therapy. However, combining ICI therapies with transarterial chemoembolization has shown enhanced […]
Category: General Surgery
Post-surgery adjuvant treatment improves outcomes for HCC patients
A study of 649 hepatocellular carcinoma (HCC) patients revealed that those with triple positive tumor markers experienced significantly improved recurrence-free survival when receiving postoperative adjuvant therapy (30.0 months) compared to those who did not (19.6 months, p=0.019). The analysis also showed that the number of positive tumor markers was linked to various clinical and pathological […]
Wrapping technique reduces major complications in pancreaticoduodenectomy
A systematic review and meta-analysis revealed that arterial and anastomotic wrapping significantly decreases major complications in pancreaticoduodenectomy. Specifically, researchers noted a reduction in postpancreatectomy hemorrhage (OR 0.47; p < 0.001) and postoperative pancreatic fistula with omental wrapping (OR 0.48; p = 0.002). The technique did not increase operative time or reoperation rates, and delayed gastric […]
Low skeletal muscle index/systemic immune-inflammation index predicts poor survival in HCC patients
A study of 1,504 patients with hepatocellular carcinoma revealed that a low skeletal muscle index/systemic immune-inflammation index (SMI/SII) ratio is a significant independent prognostic factor for poor overall survival (OS). Results showed the high SMI/SII group had a notably better OS compared to the low SMI/SII group across multiple cohorts. Additionally, patients with elevated SMI/SII […]
Neoadjuvant immunochemotherapy improves long-term outcomes in esophageal cancer.
The study reveals that neoadjuvant immunochemotherapy significantly enhances long-term survival for patients with locally advanced esophageal squamous carcinoma, particularly those with stage III disease or suspected lymph node involvement. An analysis of 397 patients showed that while pathologic complete response rates were similar between immunochemotherapy and chemoradiotherapy groups, the former led to better overall survival […]
Endoscopic resection proves effective for certain esophageal tumors
The study identifies significant clinicopathological differences between esophageal gastrointestinal stromal tumors (e-gist) and gastric gastrointestinal stromal tumors (g-gist), noting e-gist’s stronger male predominance, older median age, and increased tumor size and ulceration. Remarkably, endoscopic resection (ER) is found to be comparably effective to surgical resection for selected e-gist patients (tumors ≤5 cm without ulceration), with […]
Low liver-to-spleen ratio indicates higher intrahepatic recurrence risk
Analysis of 208 patients post-curative hepatectomy for hepatocellular carcinoma revealed that a low liver-to-spleen ratio (LSR) is a strong predictor of intrahepatic recurrence. Specifically, 53% experienced recurrence, with significantly higher rates in those with low LSR values (
Elevated levels of EMP and STM predict severe pancreatitis outcomes
Dynamic changes in plasma endothelial microparticles (EMP) and soluble thrombomodulin (STM) levels significantly correlate with prognosis in severe acute pancreatitis (SAP). In a study of 128 SAP patients, higher EMP and STM levels were linked to increased mortality rates. Combined detection had a notable sensitivity of 92.39% and specificity of 90.54%, demonstrating superior prognostic accuracy […]
Modified stapled hemorrhoidopexy shows improved outcomes over conventional method
A prospective randomized trial involving 110 patients revealed that modified partial stapled hemorrhoidopexy (mpsh) significantly reduced average and peak postoperative pain scores compared to conventional hemorrhoidectomy (ch). Patients in the mpsh group reported shorter laxative usage and earlier return to work, alongside higher satisfaction levels and better symptom improvement. Although the overall complication rates were […]
Updated guidelines improve colorectal cancer surveillance in IBD
New guidelines emphasize the ongoing colorectal cancer risk in inflammatory bowel disease (IBD) patients despite improved therapies. Developed by UK stakeholders, the guidelines present 73 statements focusing on factors including surveillance intervals, service organization, and the importance of patient collaboration. Key areas include dysplasia management, risk assessment, and the integration of advanced technologies like artificial […]